Financials Immunovia AB London S.E.

Stocks

Market Closed - London S.E. 15:45:34 03/11/2025 GMT			5-day change	1st Jan Change
31.92 ^SEK	-32.03%		+18,809.95%	+13,658.62%

08-18	Seven stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW
08-13	Immunovia: Strong demand for blood test for pancreatic cancer, survey shows	FW

Fiscal Period: December	2021	2022	2024	2025	2026	2027	2028
Net sales ¹	0.956	1.204	-	0.752	3.2	17.3	55
Change	-	25.94%	-	-	325.53%	440.62%	217.92%
EBITDA ¹	-147.6	-166.2	-	-78.06	-85	-74	-42
Change	-	-12.65%	-	-	-8.89%	12.94%	43.24%
EBIT ¹	-166.6	-191.2	-	-80.38	-88	-76	-45
Change	-	-14.72%	-	-	-9.47%	13.64%	40.79%
Interest Paid	-	-	-	-65.53	-	-	-
Earnings before Tax (EBT) ¹	-156	-168.1	-	-145.9	-87	-76	-45
Change	-	-7.77%	-	-	40.38%	12.64%	40.79%
Net income ¹	-156	-168.1	-76.54	-145.9	-87	-76	-45
Change	-	-7.77%	-	-90.64%	40.38%	12.64%	40.79%
Announcement Date	17/02/22	23/02/23	25/02/25	24/02/26	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2021 Q3	2021 Q4	2022 Q2	2022 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2
Net sales ¹	0.386	0.344	0.108	0.381	-	0.201	0.096	0.101	0.354	0.424	0.406	1	2	4	-
Change	-	-10.88%	-68.6%	252.78%	-	-	-52.24%	5.21%	250.5%	19.77%	-4.25%	146.31%	100%	100%	-
EBITDA ¹	-33.72	-44.68	-44.45	-35.78	-	-18.03	-19.73	-24.6	-15.7	-18.42	-22.14	-23	-22	-18	-18
Change	-	-32.51%	0.53%	19.5%	-	-	-9.45%	-24.69%	36.17%	-17.29%	-20.22%	-3.88%	4.35%	18.18%	0%
EBIT ¹	-39.94	-50.88	-50.79	-41.92	-	-18.91	-20.05	-25.02	-16.38	-18.43	-22.88	-23	-23	-19	-19
Change	-	-27.39%	0.18%	17.47%	-	-	-6.06%	-24.78%	34.55%	-12.57%	-24.11%	-0.53%	0%	17.39%	0%
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-36.13	-47.13	-33.73	-22.93	-	-57.79	-41.05	-29.74	-17.33	-18.43	-22.83	-23	-23	-19	-19
Change	-	-30.44%	28.44%	32%	-	-	28.97%	27.54%	41.75%	-6.39%	-23.84%	-0.75%	0%	17.39%	0%
Net income ¹	-36.13	-47.13	-33.73	-22.93	3.07	-57.79	-41.05	-29.74	-17.33	-18.43	-22.83	-23	-23	-19	-19
Change	-	-30.44%	28.44%	32%	113.39%	-1,982.48%	28.97%	27.54%	41.75%	-6.39%	-23.84%	-0.75%	0%	17.39%	0%
Announcement Date	11/11/21	17/02/22	24/08/22	10/11/22	25/02/25	14/05/25	28/08/25	26/11/25	24/02/26	07/05/26	06/08/26	-	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2021	2022	2024	2025	2026	2027	2028
Net Debt ¹	-254	-68.5	-	-76.6	-35	-30	-55
Change	-	73.03%	-	-	54.31%	14.29%	-83.33%
Announcement Date	17/02/22	23/02/23	25/02/25	24/02/26	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2021	2022	2025	2026	2027	2028
CAPEX ¹	24.18	1.624	-	-	-	-
Change	-	-93.28%	-	-	-	-
Free Cash Flow (FCF) ¹	-155.8	-177.2	-83.96	-87	-80	-50
Change	-	-13.78%	-	-3.62%	8.05%	37.5%
Announcement Date	17/02/22	23/02/23	24/02/26	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-15,435.67%	-13,807.06%	-	-	-10,380.32%	-2,656.25%	-427.75%	-76.36%
EBIT Margin (%)	-17,429.71%	-15,876.25%	-	-	-10,689.49%	-2,750%	-439.31%	-81.82%
EBT Margin (%)	-16,314.44%	-13,961.13%	-	-	-19,403.59%	-2,718.75%	-439.31%	-81.82%
Net margin (%)	-16,314.44%	-13,961.13%	-	-	-19,403.59%	-2,718.75%	-439.31%	-81.82%
FCF margin (%)	-16,291.84%	-14,718.11%	-	-	-11,164.76%	-2,718.75%	-462.43%	-90.91%
FCF / Net Income (%)	99.86%	105.42%	-	-	57.54%	100%	105.26%	111.11%
Profitability
ROA	-	-	-	-	-240.68%	-54%	-11%	-
ROE	-30.19%	-	-	-	-382.06%	-78%	-23%	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	2,529.71%	134.88%	-	-	-	-	-	-
CAPEX / EBITDA (%)	-16.39%	-0.98%	-	-	-	-	-	-
CAPEX / FCF (%)	-15.53%	-0.92%	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-781	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	1,917	1,077	-	-	-	-	-	-
Change	-	-43.82%	-	-	-	-	-	-
EPS ¹	-689	-743	-	-93	-0.42	-0.1	-0.04	-0.02
Change	-	-7.84%	-	-	99.55%	76.19%	60%	50%
Nbr of stocks (in thousands)	22,632	22,632	-	169,711	672,667	672,667	672,667	672,667
Announcement Date	17/02/22	23/02/23	-	25/02/25	24/02/26	-	-	-